Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000127553 | SCV000171130 | benign | not specified | 2013-11-05 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000127553 | SCV000309151 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000471756 | SCV000556252 | benign | Progressive sclerosing poliodystrophy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000127553 | SCV000614736 | benign | not specified | 2017-07-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312921 | SCV000847663 | likely benign | Inborn genetic diseases | 2016-06-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Wong Mito Lab, |
RCV000471756 | SCV000887090 | benign | Progressive sclerosing poliodystrophy | 2018-10-01 | criteria provided, single submitter | clinical testing | The NM_002693.2:c.852C>T (NP_002684.1:p.Ile284=) [GRCH38: NC_000015.10:g.89330084G>A] variant in POLG gene is interpretated to be a Benign based on ACMG guidelines (PMID: 25741868). This variant meets the following evidence codes reported in the ACMG-guideline. BS1:The minor allele frequency of this allele is high for Mitochondrial DNA depletion syndrome 4A (Alpers type). BS2:Observation of the variant in controls is inconsistent with penetrance of Mitochondrial DNA depletion syndrome 4A (Alpers type). Based on the evidence criteria codes applied, the variant is suggested to be Benign. |
Breakthrough Genomics, |
RCV004704985 | SCV005213951 | likely benign | not provided | criteria provided, single submitter | not provided |